The present invention relates to a process for the preparation of deutetrabenazine. the process comprising reacting a compound of formula V with dehydrogenating reagent to give a compound of formula IV; reacting the compound of formula IV with a deuterated methylating agent to obtain compound of formula II; reacting...

ABSTRACT OF THE INVENTION “PROCESS FOR PREPARATION OF LASMIDITAN” The present invention relates to a process for the preparation of lasmiditan, a compound of formula I, or pharmaceutically acceptable salts thereof, the process comprising reacting a compound of formula IV with morpholine to obtain a compound of for...

The present invention relates to crystalline abrocitinib characterized by X-ray powder diffraction (XRPD) spectrum having peak reflections at about 12.9, 14.7, 19.4, 23.2 and 25.2 ±0.2 degrees 2 theta, and process for its preparation. The present invention relates to amorphous solid dispersion comprising abrocitinib...

ABSTRACT The present invention relates to a process for the preparation of diroximel fumarate, a compound of formula I. The present invention relates to amorphous solid dispersion comprising diroximel fumarate, a compound of formula I or salt thereof together with at least one pharmaceutically acceptable carrier an...

ABSTRACT OF THE INVENTION “PROCESS FOR PREPARATION OF FAVIPIRAVIR” The present invention relates to a process for the preparation of favipiravir and salts thereof. The present invention also relates to salts of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile with inorganic base, process for their preparation and convers...

“PROCESS FOR THE PREPARATION OF VERAPAMIL” The present invention relates to a process for the preparation of a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl), monohydrochloride (verapamil hydrochloride, a compound of formula I), the process comprising treating verapamil (a com...

Abstract The present invention relates to process for preparation N1-(5-Chloropyridin-2-yl)-N2-[(1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-ylcarboxamido)cyclohexyl]oxamide p-toluene sulfonate monohydrate [edoxaban tosylate monohydrate], the compound of formula I, com...

The present invention relates to a crystalline form of isavuconazonium sulfate. The present invention also relates to a process for preparation of isavuconazonium sulfate and a pharmaceutical composition containing the crystalline isavuconazonium sulfate. The invention also relates to a method for the treatment of f...

The present invention relates to a process for the preparation of brivaracetam, a compound of formula I and salts thereof. The present invention also relates to a compound of formula II and a compound of formula IIA, process for its preparation and conversion thereof to brivaracetam, the compound of formula I. ...

The present invention relates to a process for the preparation of roxadustat a compound of Formula I. More particularly the present invention relates to a process for the preparation of co-crystal of roxadustat and further more particularly the present invention relates to process for preparation of co-crystal of r...

ABSTRACT “PROCESS FOR PREPARATION OF TAFAMIDIS AND SALTS THEREOF” The present invention relates to process for the preparation of crystalline Form 4 of tafamidis. The present invention also relates to salts of tafamidis and process of preparation of salts of tafamidis.

ABSTRACT The present invention relates to a process for the preparation of lercanidipine or salt thereof. More particularly the present invention relates to a process for the preparation of lercanidipine by reacting compound of formula II with a compound of formula III and further more particularly the present i...

The present invention relates to process for the preparation of benvitimod or salt thereof.

The present invention relates to process for the preparation of lobeglitazone or salt thereof.

“PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF” The present invention relates to a process for the preparation of olaparib. The present invention also relates to a novel crystalline form of olaparib, and a process for its preparation. Further, the present invention also relates to a pharm...

The present invention relates to a process for the preparation of omadacycline tosylate. The present invention also relates to an amorphous form of omadacycline tosylate, and a process for its preparation. Further, the process for amorphous omadacycline tosylate comprises a solvent mixture. The present invention fu...

The present invention provides a process for the preparation of ruxolitinib or a salt thereof

ABSTRACT “PROCESS FOR PREPARATION OF SELUMETINIB AND SALTS THEREOF” The present invention is related to a process of selumetinib, a compound of formula II, or an acid addition salt thereof. The present invention is also related to an intermediate compound of formula III or a salt or a hydrate thereof, and its us...

ABSTRACT PROCESS FOR PREPARATION OF RUXOLITINIB The present invention provides a process for the preparation of ruxolitinib or a pharmaceutically acceptable salt thereof. In particular, the present invention provides a process for the preparation of crystalline (R)-ruxolitinib phosphate. The present invention al...

PROCESS FOR THE PREPARATION OF VILOXAZINE HYDROCHLORIDE” The present invention relates to an improved process for the preparation of viloxazine or its pharmaceutically acceptable salts such as the hydrochloride salt. Further, the present invention relates to a novel compound designated herein as viloxazine acetat...

Systems and methods for Interactive Learning Abstract The present invention covers systems and computer implemented methods of creating and providing virtual interactive learning in an organization for its employees by way of gamification of standard operating procedures. ...

ABSTRACT “PROCESS FOR THE PREPARATION OF TAFAMIDIS” The present invention relates to a process for the preparation of crystalline Form 4 of tafamidis from tafamidis meglumine salt. To, The Controller of Patents The Patent Office Branch, Mumbai

ABSTRACT “PROCESS FOR PREPARATION OF RELUGOLIX” The present invention is related to a process for the preparation of relugolix, a compound of formula I, also known as N- [4-[1-[(2,6-difluoro phenyl) methyl]-5-[(dimethyl amino]- methyl]-3-(6-methoxy-3-pyridazinyl]-2,4-dioxo-1,2,3,4-tetrahydro-thieno[2,3-d] pyri...

PROCESS FOR THE PREPARATION OF PALBOCICLIB. The present invention relates to an improved process for the preparation of palbociclib. The present invention also relates to a novel crystalline Form G of tert-butyl 4-(6-{[6-(1-butoxyethenyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}p...

PROCESS FOR THE PREPARATION OF BELUMOSUDIL MESYLATE AND ITS CRYSTALLINE FORM” The present invention relates to a process for the preparation of belumosudil mesylate and its crystalline form. Further, the present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of the c...

PROCESS FOR THE PREPARATION OF TIVOZANIB OR A SALT THEREOF ABSTRACT The present invention relates to a process for the preparation of tivozanib or a pharmaceutically acceptable salt or a hydrate thereof. The present invention particularly relates to a process for the preparation of tivozanib hydrochloride or a h...

ABSTRACT “PROCESS FOR THE PREPARATION OF DEUCRAVACITINIB, AND CRYSTALLINE FORMS THEREOF” The present invention relates to a process for the preparation of deucravacitinib. The present invention also relates to a novel intermediate of deucravacitinib, process for its preparation, and use thereof in the process for ...

The present invention relates to a solid dispersion comprising daprodustat or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The present invention also relates to a process for the preparation of the solid dispersion, a pharmaceutical composition comprising the solid dispersio...

The present invention relates to a solid dispersion comprising tapinarof or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. The present invention also relates to a process for the preparation of the solid dispersion, a pharmaceutical composition comprising the solid dispersio...

ABSTRACT “CRYSTALLINE SOLVATE OF RELUGOLIX AND A PROCESS FOR ITS PREPARATION” The present invention relates to a novel crystalline solvate of relugolix, particularly the dimethylacetamide solvate, and a process for its preparation. Also, the present invention relates to a crystalline dimethylacetamide solvate ...

The present invention relates to a solid dispersion comprising Niraparib or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The present invention also relates to a process for the preparation of the solid dispersion, a pharmaceutical composition comprising the solid dispersion,...

Present invention provides a process for the preparation of pure propranolol or its hydrochloride salt (propranolol hydrochloride), wherein the resulting propranolol or propranolol hydrochloride is substantially free of N-nitrosamine impurity.

The present invention provides a process for the preparation of tofacitinib and an intermediate thereof. Particularly, the present invention relates to a process for the preparation of a salt of 7H-pyrrolo[2,3-d] pyrimidine-2,4-diol, and its use in the preparation of tofacitinib or a pharmaceutically acceptable sal...